Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Ovarian cancer ranks as the leading cause of death among gynecological malignancies[1, 2]. Areca nut has demonstrated notable antitumor activity, yet its underlying mechanism remains incompletely understood.
Objective: To explore the potential of areca nut - derived active ingredients in regulating ovarian cancer progression via the PTEN/AKT1 signaling axis.
Methods: Targets related to areca nut were screened from the TCMSP database, while ovarian - cancer - associated targets were retrieved from GeneCards and DisGeNET databases. Intersection targets were identified using Venn analysis. Core pathways were annotated through enrichment analysis with Metascape and DAVID databases. Molecular docking was performed to validate the binding energy intensity between areca nut active ingredients and their corresponding receptors. In addition, the effect of arecoline on ovarian cancer cells was investigated in vitro.
Results: A total of 50 common targets were identified from 139 areca nut - related targets and 1914 ovarian cancer - associated targets. Pathway enrichment analysis revealed significant enrichment of the PI3K/AKT pathway. The core targets, PTEN (-5.3 kJ/mol) and AKT1 (-5.4 kJ/mol), exhibited strong binding to the active components of areca nut. Moreover, arecoline inhibited the proliferation and induced apoptosis in ovarian cancer cells.
Conclusion: In conclusion, this study provides a solid scientific basis for exploring the action mechanism of areca nut.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbrc.2025.151943 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence of Oral Potentially Malignant Disorders in Smokeless Tobacco Users With or Without Areca Nut: A Meta-Analysis.
J Oral Pathol Med
September 2025
Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Arabian Gulf University, Manama, Bahrain.
Background: Smokeless tobacco (SLT) use is a major global risk factor for oral potentially malignant disorders (OPMDs). However, the differential impact of SLT product composition, particularly tobacco-only versus combined tobacco-areca nut products, on OPMD prevalence remains inadequately characterized.
Objective: To compare the pooled prevalence of OPMDs between users of tobacco-only SLT and users of SLT containing both tobacco and areca nut.
YY1 lactylation promotes fibroblast senescence by targeting the PU.1-BTG2 axis to promote oral submucous fibrosis.
Chem Biol Interact
August 2025
Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China; Department of Oral Medicine, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China; Institute of Oral Precancerous Lesions, Central South Uni
Oral submucous fibrosis (OSF) is a chronic fibrotic disease common in Asia-Pacific regions and strongly linked to long-term areca nut chewing. Fibroblast senescence is known to contribute to tissue fibrosis, but the molecular mechanisms behind it remain unclear. In this study, we explored how arecoline, a key component of areca nut, influences fibroblast behavior.
View Article and Find Full Text PDFThe Areca Nut and Oral Submucosal Fibrosis: A Narrative Review.
Dent J (Basel)
August 2025
College of Dentistry, University of Saskatchewan, 105 Wiggins Road, Saskatoon, SK S7N 5E4, Canada.
The areca nut (AN) is chewed by approximately 600 million people worldwide. Among AN chewers, ~5% develop oral submucosal fibrosis (OSF), a progressive fibrotic disorder of the oral cavity. OSF is characterized by subepithelial fibrosis and mucosal rigidity, leading to restricted mouth opening, difficulty in mastication, deglutition, and speech.
View Article and Find Full Text PDFPrevalence of tobacco use and effectiveness of physician's brief advice on tobacco cessation in the context of type 2 diabetes mellitus outpatients: A cross-sectional study.
Ind Psychiatry J
July 2025
Consultant in Medicine at MMFHA Joshi Hospital, Pune, Maharashtra, India.
Background: Tobacco use is the largest preventable risk of non-communicable diseases (NCDs). Moreover, tobacco use interferes with glycaemic control, and there is a proven link between smoking and diabetes complications.
Aim: This cross-sectional study investigates the prevalence of tobacco use and the effect of advice about quitting and its impact at one-month and one-year follow-ups in outpatient type 2 diabetics.